Press release
Meningococcal Vaccines Market: Pathway to $6.18 Billion by 2029 Amid Increase in Healthcare Spend and Emergence of New Strains
Meningococcal Vaccines Market Size
What Is the Projected Market Size of the Global Meningococcal Vaccines Market and Its Growth Rate?
• The meningococcal vaccines market size is expected to grow from $3.89 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. This growth can be attributed to disease incidence, global travel trends, healthcare infrastructure, epidemic preparedness, and health insurance coverage.
• Further, the market size is anticipated to soar to $6.18 billion in 2029 at a CAGR of 9.5%. This surge in market growth can be traced back to the emergence of new strains, increasing globalization, growing healthcare investments, health initiatives, and a changing regulatory landscape.
What is Driving the Growth in the Meningococcal Vaccines Market?
An increase in healthcare spending is a significant factor driving the growth of the meningococcal vaccine market. The rising costs of newer vaccine generations compared to their predecessors has sparked debates on the justification of their prices against their benefits. Evaluating the comprehensive social and economic advantages of vaccination has become a focal point in literature on valuing vaccination. For instance, in May 2022, the American Medical Association reported an increase of 9.7% in healthcare spending in the United States, totaling $4.1 trillion. This pace exceeds the growth rate of 4.3% in 2019, subsequently fueling the meningococcal vaccine market growth.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8013&type=smp
Who Are the Key Players Driving Meningococcal Vaccines Market Growth?
The following companies are major players propelling the growth of the meningococcal vaccines market:
• Pfizer Inc.
• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co. Inc.
• Serum Institute of India Pvt. Ltd.
• Bio-Manguinhos
• Walvax Biotechnology Co. Ltd.
• Bavarian Nordic A/S
• Hualan Biological Engineering Inc.
• China National Pharmaceutical Group (Sinopharm)
• Bharat Biotech
• Incepta Pharmaceuticals Ltd.
• Biological E. Limited
• Chongqing Zhifei Biological Products Co. Ltd.
• Biokangtai
• Biomed Pvt Ltd
• Biocine SCL
• Panacea Biotec Ltd
• Grifols S.A
• CSL Limited
• Minhai Biotechnology Co. Ltd.
• Chiron Behring Vaccines Pvt. Ltd.
• Shenzhen Kangtai Biological Products Co. Ltd.
What Are the Key Trends in the Meningococcal Vaccines Market?
Key trends in the meningococcal vaccines market include:
• Personalized vaccines
• Digital vaccination records
• Gene editing technologies
• Multi-valent vaccines
• Subscription-based vaccine models
What Are the Segments of the Global Meningococcal Vaccines Market?
The global meningococcal vaccines market is segmented as follows:
1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
2) By Serotype: Men Acwy, Men B/Bc, Men C
3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults
4) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Channels
5) By End user: Hospitals, Research, Academic Institutes
Which Region Leads the Meningococcal Vaccines Market?
North America held the largest share in the meningococcal vaccines market in 2024. However, Asia-Pacific is projected to emerge as the fastest-growing region in the meningococcal vaccines market during the forecast period.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
What Is Covered In The Meningococcal Vaccines Market Global Market Report?
- Market Size Analysis: Analyze the Meningococcal Vaccines Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Meningococcal Vaccines Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Meningococcal Vaccines Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Meningococcal Vaccines Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report
https://www.thebusinessresearchcompany.com/customise?id=8013&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccines Market: Pathway to $6.18 Billion by 2029 Amid Increase in Healthcare Spend and Emergence of New Strains here
News-ID: 3841034 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Vaccine
Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
AstraZeneca
Bharat Biotech
Dynavax Technologies Corporation
GlaxoSmithKline
Johnson & Johnson
Merck and Co
Novartis
Pfizer
Sanofi Pasteur
Serum Institute of India
The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing…
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market…
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market.
Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top…
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze…
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Measles Vaccine Market Production and Demand Analysis 2019 to 2025
Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025
Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025
Measles Vaccine Market to Insight By 2025: Top Key Vendors
The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the…
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016.
Paediatric vaccine market is a billion dollar market accounting for a substantial proportion…
